Innovation Pharmaceuticals Inc (IPIX)

[scottsmith]

Kevetrin is a 1b trial, no? Maybe I'm wrong about that. If K is a 1b trial, I wouldn't consider that a mid phase trial. Personally, I wouldn't consider UP a mid phase trial either. A 17 person, 2a PoC trial doesn't meet that definition in my opinion.

I think we all care about the science. But the science is actually only one of multiple elements that determines a successful investment. Matter of fact, "the science" is the least controllable element to a bio investment. Financial, management, public relations, employees, trial design...can all be controlled more than "the science". Food for thought.